Literature DB >> 21666216

Risk analysis for measles reintroduction after global certification of eradication.

Raymond Sanders1, Alya Dabbagh, David Featherstone.   

Abstract

BACKGROUND: Measles virus will continue to exist after certification of global eradication as virus stocks and infectious materials held in laboratories, in persistently and chronically infected individuals, and possibly in undetected foci of transmission. A literature search was undertaken to identify and evaluate the main risks for reintroduction of measles transmission in the absence of universal measles immunization.
METHODS: A qualitative risk assessment was conducted following a series of literature searches using the PubMed database.
RESULTS: If the criteria for global certification of eradication are stringent and require rigorous validation, then the risk of undetected measles transmission after certification is very low. Risk of unintentional reintroduction from any source, including persistent infections and laboratory materials is low to very low but depends on the extent of measles vaccine use. If immunization levels decrease, measles will become a credible agent for bioterrorism through intentional release.
CONCLUSIONS: Posteradication risks are low and should not deter any attempt at measles eradication. More information on measles transmission dynamics and the role of atypical infections is required to determine requirements for global certification of eradication. Posteradication risks would be minimized through development and implementation of an international risk management strategy, including requirements for a posteradication vaccine stockpile.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666216     DOI: 10.1093/infdis/jir133

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 2.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

3.  Dolphin morbillivirus infection in a captive harbor seal (Phoca vitulina).

Authors:  Sandro Mazzariol; Simone Peletto; Alessandra Mondin; Cinzia Centelleghe; Giovanni Di Guardo; Cristina Esmeralda Di Francesco; Cristina Casalone; Pier Luigi Acutis
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

4.  The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Authors:  Maino Tahara; Shinji Ohno; Kouji Sakai; Yuri Ito; Hideo Fukuhara; Katsuhiro Komase; Melinda A Brindley; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

5.  Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.

Authors:  Maino Tahara; Yuri Ito; Melinda A Brindley; Xuemin Ma; Jilan He; Songtao Xu; Hideo Fukuhara; Kouji Sakai; Katsuhiro Komase; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 6.  Synergizing vaccinations with therapeutics for measles eradication.

Authors:  Richard K Plemper; Anthea L Hammond
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

7.  Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus.

Authors:  Rory D de Vries; Martin Ludlow; R Joyce Verburgh; Geert van Amerongen; Selma Yüksel; D Tien Nguyen; Stephen McQuaid; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

Review 8.  Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.

Authors:  Maino Tahara; Jean-Philippe Bürckert; Kazuhiko Kanou; Katsumi Maenaka; Claude P Muller; Makoto Takeda
Journal:  Viruses       Date:  2016-08-02       Impact factor: 5.048

9.  Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK.

Authors:  Kartini Gadroen; Caitlin N Dodd; David A M C van de Vijver; Rik L de Swart; Gwen M C Masclee; Maria A J de Ridder; Daniel Weibel; Michael J Mina; Bryan T Grenfell; Miriam C J M Sturkenboom
Journal:  BMJ Open       Date:  2018-11-08       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.